Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sudip Bandopadhyay of Destimoney Securities is of the view that one may prefer midcap stocks like Mangalam Cement, Mahindra CIE and Ramkrishna Forgings.
Watch the interview of Sameet Chavan of Angel Broking who shared his readings and outlook on specific stocks and sector & Kalpesh Ashar of Full Circle Financial Planners & Advisors answered few personal finance queries.
According to Sameet Chavan of Angel Broking, one may buy Sun Pharmaceutical Industries and Dr Reddy's Laboratories on dips.
Rahul Mohindar of viratechindia.com is of the view that Ipca Labs is an attractive buy.
Pankaj Murarka of Axis Asset Management is of the view that one may prefer midcap stocks.
Vikas Khemani ,CEO at Edelweiss Securities is of the view that one may prefer banking and auto space and feels that midcaps are opportunities on correction.
Kunj Bansal of Centrum Wealth Management is of the view that one may prefer midcap pharma stocks on correction.
Taher Badshah of Motilal Oswal AMC is of the view that one will keep getting opportunities on mid-size companies.
Taher Badshah of Motilal Oswal AMC is of the view that one may prefer midcap pharma companies.
Pharma Analyst, Abhishek Sharma of IIFL spoke with Ekta Batra & Anuj Singhal of CNBC-TV18. He shared his reading and outlook on the pharmaceutical space.
Mayuresh Joshi of Angel Broking is of the view that one may hold Ipca Laboratories.
Sudarshan Sukhani of s2analytics.com recommends holding Ipca Laboratories.
Taher Badshah of Motilal Oswal AMC is of the view that one may hold IPCA Laboratories with a long term view.
Here are top 10 stocks to keep an eye on March 25 - Tata Motor DVR, Tata Motors, Bharti Airtel, Idea Cellular, GMR Infra, Ipca Labs, IOC, BPCL, Oil India and NTPC.
Devang Mehta of Anand Rathi Financial Services is of the view that Sun Pharma and Lupin still remains the top picks.
Sudarshan Sukhani of s2analytics.com is of the view that one may prefer pharma stocks.
Anmol Ganjoo of JM Financial Institutional Securities is of the view that one may prefer Dr Reddy's Laboratories, Lupin, Cipla, Ipca Labs and Torrent Pharma.
Dilip Bhat of Prabhudas Lilladher is of the view that one may prefer MphasiS, KPIT Tech and Exide Industries.
Amit Harchekar of A PLUS Analytics is of the view that one can go long in IPCA Laboratories with a target of Rs 785-800.
Sharmila Joshi of sharmilajoshi.com is of the view that one may prefer Wockhardt.
Here are top 10 stocks to keep an eye on February 9 - Tata Power, Reliance Infra, DLF, Tata Steel, Jet Airways, Jammu and Kashmir Bank (J&K) Bank, Marico Kaya, Apollo Tyres, IPCA Labs, Balmer Lawrie, TV Today, Technocraft, Vascon Engineers, Pricol AND VA Tech Wabag.
Here are top 10 stocks to keep an eye on January 23 - ICICI Bank, Axis Bank, Cairn India, Prestige Estates, Biocon, Ipca Labs, Polaris, Phillips Carbon, Mahindra Holidays and HCL Infosystems.
Here are top 10 stocks to focus on January 13 - Cairn India, Jet Airways, Apollo Tyres, Ceat, Crompton Greaves, Bank Nifty, Hindalco, CMC, Clariant Chemicals and Spicejet. We are also watching Dr Reddy's, Sun Pharma, Ipca Labs, Lupin, Cipla, ACC and Ultratech.
Here are top 10 stocks to focus on December 23 - HDFC, SBI, Bank Nifty, Ipca Labs, HCL Tech, Intellect Design Arena, Max India, Rel Cap, NTPC and Gujarat Pipavav.
Mayuresh Joshi, VP- Institution at Angel Broking is of the view that Ipca Labs is the preferred bet from the midcap pharma space.